News

Published on 30 May 2024 on Zacks via Yahoo Finance

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio


Article preview image

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

NYSE.NVO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...

Over the last few years, some of the best-performing stocks in the broader healthcare space have ...

Motley Fool via Yahoo Finance 2 Jun 2024

This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are the two most valuable healthcare companies...

Motley Fool via Yahoo Finance 1 Jun 2024

Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?

Yet, the company continues to enjoy strong momentum. In early May, Novo Nordisk stock pulled back...

Investor's Business Daily 31 May 2024

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new ...

Zacks via Yahoo Finance 30 May 2024

...Loss ETF (OZEM) Is Essentially A Play On Eli Lilly And Novo Nordisk - Novo Nordisk (NYSE:NVO),...

The recently launched Roundhill GLP-1 & Weight Loss ETF OZEM is gaining traction among investors,...

Benzinga 30 May 2024

Ozempic and weight loss drug shortages can now be tracked by patients

Several...all currently in limited supply due to increased demand, according to the U.S Food and...

Quartz 29 May 2024

...-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply - Tema Obesity...

The global market for weight-loss drugs is expected to reach a staggering $150 billion by the ear...

Benzinga 29 May 2024

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System Novo ...

Benzinga via Yahoo Finance 28 May 2024

Dow Jones Tech Giant Apple, AI Leader CrowdStrike Eye Buy Points

An essential resource for daily breakouts is IBD MarketSurge's "Breaking Out Today" list. It show...

Investor's Business Daily 28 May 2024

Ozempic Maker Novo Nordisk's Increasing Influence On Denmark's Employment Raises Economic Concerns -...

Pharmaceutical titan, Novo Nordisk A/S NVO, has had a significant impact on Denmark’s employment ...

Benzinga 28 May 2024